Riskpilot← Back to searchSign inGet full accessCONVATEC NORWAY AS
ASActiveOrg 992780118Wergelandsveien 7, 0167 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 200812 employeeswww.convatec.no
Revenue 2024
NOK 85,7M
+2% vs 2023
EBITDA margin
3.1%
+28% vs 2023
Equity ratio
48.7%
Financial strength
Net profit 2024
NOK 2,2M
+42% vs 2023
| Revenue | NOK 85,7M | +2% |
| EBITDA | NOK 2,7M | +28% |
| Net profit | NOK 2,2M | +42% |
| Total assets | NOK 70,3M | +1% |
| Equity | NOK 34,2M | +35% |
| Employees | 12 | — |
Legal name
CONVATEC NORWAY AS
Org number
992780118
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
12. juni 2008
Share capital
NOK 100 010
Employees
12 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Wenche strøm-magnussen
Company purpose
Selskapet skal drive produksjon og salg av helseomsorgsprodukter samt alt som naturlig står i forbindelse med dette, derunder investeringer og deltagelse i andre selskaper.
Address
Wergelandsveien 7, 0167 Oslo
Website
www.convatec.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 80 038 | 85 151 | 100 530 | 84 060 | 85 706 |
| Staff expenses | −14 602 | −18 847 | −22 957 | −23 482 | −30 890 |
| EBITDA | 2 054 | 2 577 | 3 994 | 2 092 | 2 670 |
| Depreciation & amort. | −106 | −108 | −81 | −44 | −1 |
| EBIT | 1 948 | 2 469 | 3 913 | 2 048 | 2 668 |
| Net financials | 66 | 4 | 44 | 69 | 282 |
| Profit before tax | 2 014 | 2 473 | 3 957 | 2 117 | 2 951 |
| Tax | 497 | 606 | 952 | 551 | 729 |
| Net profit | 1 517 | 1 867 | 3 006 | 1 566 | 2 222 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 46 184 | 37 985 | 65 735 | 69 762 | 70 263 |
| Equity | 9 856 | 13 096 | 21 669 | 25 235 | 34 193 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 36 327 | 24 889 | 44 066 | 44 527 | 36 071 |
| Total debt | 36 327 | 24 889 | 44 066 | 44 527 | 36 071 |
EBITDA margin
3.1%
This company
15.8%
Market median
-80% vs market
20202024
Equity ratio
48.7%
This company
38.2%
Market median
+27% vs market
20202024
Return on equity
6.5%
This company
18.4%
Market median
-65% vs market
20202024
Net profit margin
2.6%
This company
8.1%
Market median
-68% vs market
20202024
Asset turnover
1.22×
This company
1.12×
Market median
+9% vs market
20202024
Debt / equity
1.05×
This company
0.62×
Market median
-69% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
WS Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (1) | ||
ØT Chief Executive Officer | Chief Executive Officer | 2020 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2023 | |
| Chairman | 2023 | |
| Former (2) | ||
| Board of Directors | 2020 – 2023 | |
| Chairman | 2020 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Convatec International Services Gmb | Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CONVATEC NORWAY AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ørjan Tvenge | Chief Executive Officer | 0 companies |
| Wenche Strøm-Magnussen | Chief Executive Officer | 0 companies |
| Behrouz Afshari Vafa | Board of Directors | 0 companies |
| Mark Edward Warren | Board of Directors | 0 companies |
| Michael Christian Remy Jensen | Chairman | 0 companies |
| Jens Waldemar Bøegh | Chairman | 0 companies |